REBECA JINGA: Open Payments
NPI 1760908677 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,697 in 240 payments from 21 companies in 2025. Trend: 2023 $3,802 · 2024 $3,732 · 2025 $4,697
Food & beverage: $4,598Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 40 | $677 |
| ABBVIE INC. | 35 | $605 |
| Galderma Laboratories, L.P. | 24 | $544 |
| Incyte Corporation | 23 | $442 |
| Lilly USA, LLC | 16 | $334 |
| E.R. Squibb & Sons, L.L.C. | 9 | $313 |
| UCB, Inc. | 17 | $299 |
| Novartis Pharmaceuticals Corporation | 17 | $270 |
| GENZYME CORPORATION | 9 | $241 |
| Organon LLC | 9 | $175 |
Products named: TREMFYA, SKYRIZI, OPZELURA, NEMLUVIO, Sotyktu, Bimzelx, DUPIXENT, EBGLYSS.
Industry payments across MA — which companies pay providers there.
